191 related articles for article (PubMed ID: 1616831)
1. Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.
Hulton SA; Risdon RA; Dillon MJ
Pediatr Nephrol; 1992 May; 6(3):239-43. PubMed ID: 1616831
[TBL] [Abstract][Full Text] [Related]
2. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
3. Does nephritic factor relate to the disease activity in hypocomplementemic membranoproliferative glomerulonephritis?
Ohi H; Tanuma Y
Nephron; 1992; 62(1):116. PubMed ID: 1436279
[No Abstract] [Full Text] [Related]
4. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.
Marinozzi MC; Chauvet S; Le Quintrec M; Mignotet M; Petitprez F; Legendre C; Cailliez M; Deschenes G; Fischbach M; Karras A; Nobili F; Pietrement C; Dragon-Durey MA; Fakhouri F; Roumenina LT; Fremeaux-Bacchi V
Kidney Int; 2017 Nov; 92(5):1232-1241. PubMed ID: 28712854
[TBL] [Abstract][Full Text] [Related]
5. Persistent low C3 levels associated with meningococcal meningitis and membranoproliferative glomerulonephritis.
Fernandez-Sola J; Monforte R; Ponz E; Lozano F; Plana M; Montoliu J; Torras A; Ingelmo M
Am J Nephrol; 1990; 10(5):426-30. PubMed ID: 2127874
[TBL] [Abstract][Full Text] [Related]
6. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
[TBL] [Abstract][Full Text] [Related]
7. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
8. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
9. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
Ohi H; Watanabe S; Seki M; Fujita T; Ohmori F; Hatano M
Nephron; 1987; 46(2):217-8. PubMed ID: 3600936
[No Abstract] [Full Text] [Related]
10. Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.
West CD; Bissler JJ
Pediatr Nephrol; 2008 Oct; 23(10):1867-76. PubMed ID: 18594868
[TBL] [Abstract][Full Text] [Related]
11. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
Watanabe S; Ohi H; Seki M; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
[No Abstract] [Full Text] [Related]
12. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
Ohi H; Yasugi T
Clin Exp Immunol; 1994 Feb; 95(2):316-21. PubMed ID: 8306508
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
Front Immunol; 2018; 9():2329. PubMed ID: 30487789
[TBL] [Abstract][Full Text] [Related]
14. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
Craddock CF; Richards NP; Powell RJ; Morgan AG
Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
[TBL] [Abstract][Full Text] [Related]
15. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
[No Abstract] [Full Text] [Related]
16. Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).
Ohi H; Watanabe S; Fujita T; Yasugi T
Clin Exp Immunol; 1992 Sep; 89(3):479-84. PubMed ID: 1516262
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.
Thompson RA; Yap PL; Brettle RB; Dunmow RE; Chapel H
Clin Exp Immunol; 1983 Apr; 52(1):153-6. PubMed ID: 6861372
[TBL] [Abstract][Full Text] [Related]
18. Hypocomplementaemia, C3 nephritic factor and type III mesangiocapillary glomerulonephritis progressing to systemic lupus erythematosus.
Sheeran TP; White RH; Raafat F; Jackson MA; Kumararatne DS; Situnayake RD
Br J Rheumatol; 1995 Jan; 34(1):90-2. PubMed ID: 7881851
[No Abstract] [Full Text] [Related]
19. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
[TBL] [Abstract][Full Text] [Related]
20. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
Michels MAHM; van de Kar NCAJ; van Kraaij SAW; Sarlea SA; Gracchi V; Engels FAPT; Dorresteijn EM; van der Deure J; Duineveld C; Wetzels JFM; van den Heuvel LPWJ; Volokhina EB
Front Immunol; 2021; 12():715704. PubMed ID: 34456924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]